PLoS ONE (Jan 2013)

A randomized controlled pilot study of home-based step training in older people using videogame technology.

  • Daniel Schoene,
  • Stephen R Lord,
  • Kim Delbaere,
  • Connie Severino,
  • Thomas A Davies,
  • Stuart T Smith

DOI
https://doi.org/10.1371/journal.pone.0057734
Journal volume & issue
Vol. 8, no. 3
p. e57734

Abstract

Read online

BackgroundStepping impairments are associated with physical and cognitive decline in older adults and increased fall risk. Exercise interventions can reduce fall risk, but adherence is often low. A new exergame involving step training may provide an enjoyable exercise alternative for preventing falls in older people.PurposeTo assess the feasibility and safety of unsupervised, home-based step pad training and determine the effectiveness of this intervention on stepping performance and associated fall risk in older people.DesignSingle-blinded two-arm randomized controlled trial comparing step pad training with control (no-intervention).Setting/participantsThirty-seven older adults residing in independent-living units of a retirement village in Sydney, Australia.InterventionIntervention group (IG) participants were provided with a computerized step pad system connected to their TVs and played a step game as often as they liked (with a recommended dose of 2-3 sessions per week for 15-20 minutes each) for eight weeks. In addition, IG participants were asked to complete a choice stepping reaction time (CSRT) task once each week.Main outcome measuresCSRT, the Physiological Profile Assessment (PPA), neuropsychological and functional mobility measures were assessed at baseline and eight week follow-up.ResultsThirty-two participants completed the study (86.5%). IG participants played a median 2.75 sessions/week and no adverse events were reported. Compared to the control group, the IG significantly improved their CSRT (F31,1 = 18.203, pConclusionsStep pad training can be safely undertaken at home to improve physical and cognitive parameters of fall risk in older people without major cognitive and physical impairments.Trial registrationAustralian New Zealand Clinical Trials Registry ACTRN12611001081909.